Kairos Pharma, LTD. Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2023 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Kairos Pharma, LTD. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2023 to Q3 2024.
  • Kairos Pharma, LTD. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$1.05M, a 236% decline year-over-year.
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.